Keyword: Bayer


17. Nubeqa

Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Erleada may have big head starts in the prostate cancer market, but Bayer and partner Orion have a new entry—and they're looking to carve out a share.

The MELLODDY project

Short for Machine Learning Ledger Orchestration for Drug Discovery, the three-year project from the Innovative Medicines Initiative hopes to build an AI platform capable of ingesting large libraries of proprietary information while protecting its confidentiality.